Ajax-Loading

AstraZeneca PLC - Other Stockholder Equity

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Stockholder-Equity" stands at 35.33 Billion United States Dollars as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Other Stockholder Equity" stands at 35.33 Billion USD. This represents a decrease of -5.54 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.1048 percent compared to the value the year prior.
The 1 year change in percent is 0.1048.
The 3 year change in percent is 0.4807.
The 5 year change in percent is 276.81.
The 10 year change in percent is 719.63.

The Serie's long term average value is 15.03 Billion United States Dollars. It's latest available value, on 09/30/2025, is 135.00 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is +1,484.13%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -9.12%.

Other Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Stockholder Equity905,699,262,464.00
LogoJohnson & Johnson - Other Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Other Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Other Stockholder Equity317,433,206,677.55
LogoNovartis AG - Other Stockholder Equity255,096,620,580.91